MENU
MDNAF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Medicenna Therapeutics (MDNAF) Earnings Date & Reports

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company... Show more

A.I. Advisor
published Earnings

MDNAF is expected to report earnings to -4 cents per share on February 12

Medicenna Therapeutics MDNAF Stock Earnings Reports
Q4'25
Est.
$-0.04
Q3'25
Est.
$-0.05
Q2'25
Est.
$-0.04
Q1'25
Beat
by $0.06
Q4'24
Est.
$-0.05
The last earnings report on November 13 showed earnings per share of -4 cents, beating the estimate of -4 cents. With 32.55K shares outstanding, the current market capitalization sits at 85.86M.
View a ticker or compare two or three
MDNAF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MDNAF showed earnings on November 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2 Bloor Street W.
Phone
+1 416 648-5555
Employees
16
Web
https://www.medicenna.com